New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
08:31 EDTAGNAllergan upgraded to Buy from Neutral at Buckingham
Buckingham upgraded Allergan (AGN) to Buy and raised its price target to $207 from $180 ahead of Valeantís (VRX) meeting Wednesday which should result in a higher bid for the company. The $207 price target reflects a higher stand-alone valuation for the company and potential balance sheet value enhancement moves.
News For AGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 21, 2015
12:30 EDTAGNGlaxoSmithKline 'admired' by Pfizer CEO, FT reports
Subscribe for More Information
07:22 EDTAGNActavis price target raised to $330 from $280 at Deutsche Bank
Subscribe for More Information
January 13, 2015
14:00 EDTAGNActavis says Allergan deal could close as early as Q1, as late as Q2
Subscribe for More Information
07:39 EDTAGNAmerican Academy of Cosmetic Surgery to hold a meeting
Subscribe for More Information
January 12, 2015
09:37 EDTAGNSupreme Court rejects Allergan appeal on generic Latisse, Bloomberg reports
08:09 EDTAGNActavis and Allergan announce early termination of HSR waiting period
Subscribe for More Information
08:07 EDTAGNActavis, Allergan announce early termination of Hart Scott Rodino waiting period
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use